FeesSafety
Pluang+

Three healthcare stocks, including Abbott, raised dividends in 2026, showing strong income growth potential.

Company Fundamentals
22 Nov 2026, 15:07 WIB
24/7 Wall Street
View Source
Bullish
Three healthcare stocks, including Abbott, raised dividends in 2026, showing strong income growth potential.

Abbott Laboratories, Medtronic, and Cigna Group each raised their dividends in 2026, highlighting the healthcare sector's resilience and steady income potential. Abbott marked its 54th consecutive year of dividend increases despite tighter earnings coverage due to a major acquisition. Medtronic offers the highest yield among the three with improving cash flow coverage, while Cigna provides the most payout cushion with strong earnings growth outlook. These dividend increases reflect confidence in healthcare demand and offer diversified income sources across medical devices and health coverage.

Abbott Laboratories trades at USD 103.00 on Pluang as of Nov 22, 2026 20:21 WIB, below its 52-week high of USD 128.90 but above the low of USD 82.57, with a dividend yield of 2.45%. Medtronic, meanwhile, is priced slightly lower at USD 99.94, closer to its 52-week high of USD 105.35 and offering a higher dividend yield of 2.88%. This contrast highlights Medtronic's relatively stronger yield despite Abbott's longer history of dividend increases.

More News (ABT)

Abbott shares drop over 17% in 2026, with 5-year investment losing value amid growth challenges.

Abbott shares drop over 17% in 2026, with 5-year investment losing value amid growth challenges.

Abbott Laboratories' stock fell 17.79% in 2026, declining from $125.29 to $103.00, underperforming the S&P 500's 1.16% gain. Despite a $21 billion acquisition of Exact Sciences and plans to spin off its nutrition business, Abbott's growth slowed due ...

Market News
Bearish
1 day ago
Continuous Ketone Monitoring market to hit $5.48B by 2036, driven by tech advances and diabetes care integration

Continuous Ketone Monitoring market to hit $5.48B by 2036, driven by tech advances and diabetes care integration

The global Continuous Ketone Monitoring (CKM) market is projected to grow from $118 million in 2026 to $5.48 billion by 2036, at a CAGR of 46.8%. Growth is fueled by rising diabetic ketoacidosis cases, adoption of continuous glucose monitoring, and u...

Market News
Bullish
1 day ago
Dividend Kings Abbott, McDonald's, and Tennant offer buying opportunities amid recent pullbacks and strategic moves.

Dividend Kings Abbott, McDonald's, and Tennant offer buying opportunities amid recent pullbacks and strategic moves.

Abbott Laboratories, McDonald's, and Tennant, all Dividend Kings with over 50 years of consecutive dividend increases, have recently seen their stock prices dip, presenting buying opportunities. Abbott plans to spin off its struggling nutrition divis...

Company Fundamentals
Bullish
2 days ago
Dividend Kings Abbott, McDonald's, and Tennant offer buying opportunities amid recent pullbacks and strategic moves.

Dividend Kings Abbott, McDonald's, and Tennant offer buying opportunities amid recent pullbacks and strategic moves.

Abbott Laboratories, McDonald's, and Tennant, all Dividend Kings with over 50 years of consecutive dividend growth, have recently seen their stock prices dip, creating buying opportunities. Abbott plans to spin off its struggling nutrition division t...

Company Fundamentals
Bullish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App